Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 21566885)

1.

New antineoplastic aza-phospholipids - synthesis, in-vitro cytotoxicity and differential cellular-sensitivity against 70 human tumor-cell lines.

Principe P, Broquet C, Paull K, Grever M, Coulomb H, Huchet M, Menciahuerta J, Braquet P.

Int J Oncol. 1994 Jan;4(1):29-36.

PMID:
21566885
3.

The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.

Wuonola MA, Palfreyman MG, Motohashi N, Kawase M, Gabay S, Gupta RR, Molnár J.

Anticancer Res. 1998 Jan-Feb;18(1A):337-48.

PMID:
9568100
4.

Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen.

Stinson SF, Alley MC, Kopp WC, Fiebig HH, Mullendore LA, Pittman AF, Kenney S, Keller J, Boyd MR.

Anticancer Res. 1992 Jul-Aug;12(4):1035-53.

PMID:
1503399
6.

2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity.

Bradshaw TD, Wrigley S, Shi DF, Schultz RJ, Paull KD, Stevens MF.

Br J Cancer. 1998 Mar;77(5):745-52.

7.

The anti-malarial artesunate is also active against cancer.

Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR.

Int J Oncol. 2001 Apr;18(4):767-73.

PMID:
11251172
9.
10.
11.
13.

A pentahalogenated monoterpene from the red alga Portieria hornemannii produces a novel cytotoxicity profile against a diverse panel of human tumor cell lines.

Fuller RW, Cardellina JH 2nd, Kato Y, Brinen LS, Clardy J, Snader KM, Boyd MR.

J Med Chem. 1992 Aug 7;35(16):3007-11.

PMID:
1501227
14.
15.

Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.

Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA.

Cancer Chemother Pharmacol. 2009 Jun;64(1):53-65. doi: 10.1007/s00280-008-0850-3. Epub 2008 Oct 19.

PMID:
18931998
16.

Antitumor agents. 155. Synthesis and biological evaluation of 3',6,7-substituted 2-phenyl-4-quinolones as antimicrotubule agents.

Li L, Wang HK, Kuo SC, Wu TS, Mauger A, Lin CM, Hamel E, Lee KH.

J Med Chem. 1994 Sep 30;37(20):3400-7.

PMID:
7932568
17.

Antitumor agents. 196. Substituted 2-thienyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization.

Zhang SX, Bastow KF, Tachibana Y, Kuo SC, Hamel E, Mauger A, Narayanan VL, Lee KH.

J Med Chem. 1999 Oct 7;42(20):4081-7.

PMID:
10514278
18.

P276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models.

Joshi KS, Rathos MJ, Mahajan P, Wagh V, Shenoy S, Bhatia D, Chile S, Sivakumar M, Maier A, Fiebig HH, Sharma S.

Mol Cancer Ther. 2007 Mar;6(3):926-34.

19.

Efficient synthesis of 6-(hetero)arylthieno[3,2-b]pyridines by Suzuki-Miyaura coupling. Evaluation of growth inhibition on human tumor cell lines, SARs and effects on the cell cycle.

Queiroz MJ, Calhelha RC, Vale-Silva LA, Pinto E, Lima RT, Vasconcelos MH.

Eur J Med Chem. 2010 Dec;45(12):5628-34. doi: 10.1016/j.ejmech.2010.09.014. Epub 2010 Sep 17.

PMID:
20926160
20.

Cytotoxic activity of synthetic aza alkyl lysophospholipids against drug sensitive and drug resistant human tumor cell lines.

Morimoto H, Broquet C, Principe P, Mencia-Huerta JM, Braquet P, Bonavida B.

Anticancer Res. 1991 Nov-Dec;11(6):2223-9.

PMID:
1776863
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk